Article | July 31, 2020

Key Considerations For Cryogenic Preservation And T Cell Viability

Source: Cytiva
cryogenics

Discerning fact from fiction when freezing T cells for cell therapies.

Cryopreservation provides critical protection for cell therapies by minimizing genetic changes. But cooling too slowly or quickly risks diminishing cell viability upon thaw. On 11 March 2020, Cytiva’s Peter Kilbride (senior research scientist) and Julie Meneghel (cryobiologist) discussed the importance of controlled-rate cryopreservation. Illustrating how mammalian cells change when frozen, they offered concrete cryopreservation strategies and identified temperatures at which it is safe to stop controlled cooling and transfer drug product to cryogenic storage.

VIEW THE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Cell & Gene? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: